The Risk of Meningioma Associated With the Use of Medroxyprogesterone Acetate

The Risk of Meningioma Associated With the Use of Medroxyprogesterone Acetate

Pfizer and Viatris Healthcare South Africa (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA), would like to inform you of the increased risk of meningioma associated with prolonged use.

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 27/02/2025
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance